European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Jesús Rodríguez‐Baño, Elena Carrara et al.|Clinical Microbiology and Infection|2021Cited by 1k
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is neededMark S. Butler, Peter Beyer, Richard A. Alm et al.|Archive ouverte UNIGE (University of Geneva)|2022Cited by 221
An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care unitsGloria Wong, Jason A. Roberts, Amy Brinkman et al.|Journal of Antimicrobial Chemotherapy|2014Cited by 211
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistanceTomislav Kostyanev, Herman Goossens, Marc J. M. Bonten et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 129
The WHO essential medicines list AWaRe book: from a list to a quality improvement systemBenedikt Huttner, Veronica Zanichelli, Loice Achieng Ombajo et al.|Clinical Microbiology and Infection|2022Cited by 125